Novartis Designs “Arogya Parivar” To Reach Real India In Its Rural Centers
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Swiss drug maker Novartis recently launched its ace anti-diabetes drug Galvus in India to take Merck's Januvia head on, but the company's larger focus seems to be shifting fast from the mega cities to the rural market where "real India lives.